Navigation Links
Elekta and Philips Establish Research Consortium to Leverage a Breakthrough in Cancer Care with Integration of a Linear Accelerator and MR Imaging
Date:10/25/2012

STOCKHOLM and AMSTERDAM, Oct. 25, 2012 /PRNewswire/ -- Elekta AB (NSE: EKTAb) and Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today announced that they will  expand a joint program to develop a breakthrough in cancer care with an imaging-treatment platform that merges radiation therapy and magnetic resonance imaging (MRI) technology in a single treatment system. The program for development will include a research consortium of leading radiation oncology centers and clinicians, which today includes the University Medical Center Utrecht (the Netherlands).

The establishment of the consortium marks the next step in the collaboration between Elekta, a pioneer in neurosurgery and radiation therapy systems and Philips, a leader in medical imaging systems. The consortium's mission will be to merge precision radiation delivery with MRI in a single MRI-guided radiation therapy system*. This will enable doctors to achieve exceptional soft tissue imaging during radiation therapy and to adapt treatment delivery in real-time for extremely precise cancer treatments.

"Bringing the superior soft tissue imaging of MRI and precise radiotherapy together in one device could potentially revolutionize cancer care," says Tomas Puusepp, President and CEO of Elekta AB. "The need to maximize therapeutic radiation on the target, while minimizing the exposure of healthy tissue is entirely driven by the best interests of the patient – they deserve the best chance for a cure and an improved quality of life. Elekta and Philips are leaders in the global healthcare community with a complete spectrum of expertise to fulfill this vision."

"Cancer is a major global disease that we hope to control with more targeted treatments," says Gene Saragnese, CEO Imaging Systems at Philips Healthcare. "MRI is emerging in oncology applications because of its excellent real-time 3D visualization of soft tissue. Together with our partners, all leaders in radiation therapy delivery, we are convinced that the integrated MRI-guided radiation therapy system has the potential to become a game changer in cancer care on a global scale."

Working with University Medical Center Utrecht, the medical device companies have built and tested a prototype system that integrates a linear accelerator and a 1.5 Tesla MRI system. The success of early tests has enabled the project to move to the next phase of development and testing by a select group of consortium partners.

"We are proud and excited about this project," adds Prof. Jan Lagendijk, Department of Radiotherapy, University Medical Center Utrecht. "Elekta, Philips and my department have strived for over a decade to make this possible. Through real-time imaging of both tumors and organs at risk, an integrated MRI-guided radiation therapy system would enable us to see more precisely than ever what we treat, and irradiate just the tumor as it moves in the body during treatment. This could potentially bring significant benefits to patients and overall healthcare economics."

Radiotherapy is one of the primary modalities used to treat cancer, either as a stand alone treatment or used with other modalities such as chemotherapy. The technique involves identifying cancerous tissue and irradiating it with high energy radiation beams in a way that maximizes sparing of healthy tissue near the tumor. Radiation therapy delivered by linear accelerators and medical imaging already play an essential role in treatment planning, delivery and after care and is a proven cost-effective and safe method for treating patients with cancer.

*The integrated MRI-guided radiation therapy system is in development and not available for sale.

For further information, please contact:

Johan Andersson Melbi, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, E-mail: johan.anderssonmelbi@elekta.com  
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, E-mail: michelle.joiner@elekta.com 
Time zone: ET: Eastern Time

Steve Klink, Philips Corporate Communications
Tel.: +31 20 5977415, E-mail: steve.klink@philips.com

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

About Royal Philips Electronics

Royal Philips Electronics (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2011 sales of EUR 22.6 billion and employs approximately 122,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming, home and portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter

 


'/>"/>
SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Elekta Launches New Version of Monaco Treatment Planning System with Segment Shape Optimization
2. ASRT Foundation and Elekta Award More Than $20,000 in Scholarships to Radiation Therapy Students
3. Elekta Technology at Work in 100 Percent of Americas Top Cancer Hospitals
4. Elekta to Showcase Revolutionary Agility Beam-shaping Innovation at Radiation Physics Annual Meeting
5. Elektas Gamma Knife and Radiation Therapy Systems for Cancer Treatment Take Top Three Places in 2012s Best in KLAS for Radiation Therapy
6. U.K. Cancer Patient is Worlds First to Benefit from Treatment Combining Elektas New Beam-shaping Innovation and High-speed Arc Therapy
7. Austrian Medical Center Upgrades Cancer Treatment System, Improves Patient Care with Elektas Agility Beam-shaping Device
8. Elekta and The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Sign Strategic Alliance to Further Cancer Research
9. Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting
10. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
11. Philips and Biocompatibles Team-up to Advance Image Guided Transarterial Embolizations in Interventional Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... 2016 Research ... the  "Europe Thrombocytopenia Market and Competitive ... their offering.       (Logo: ... latest research Europe Thrombocytopenia Market and ... comprehensive insights into Thrombocytopenia pipeline products, ...
(Date:5/4/2016)... -- Compass Diversified Holdings (NYSE: CODI ) ("CODI," ... middle market businesses, announced today its consolidated operating results ... First Quarter 2016 Highlights , Generated Cash ... Flow") of $13.6 million for the first quarter of ... for the first quarter of 2016; , Paid ...
(Date:5/4/2016)... Israel , May 4, 2016 ... BiondVax,s CEO, Dr. Ron Babecoff , will be attending ... York City . On Thursday, May 5, ... a conference presented by Joseph Gunner & Co, ... The BiondVax presentation that Dr. Babecoff will be using is ...
Breaking Medicine Technology:
(Date:5/6/2016)... ... May 06, 2016 , ... ... Konur, CEO of Cardiovascular Institute of the South announced today that Dr. Robert ... live case of an Intravascular Ultrasound Guided Coronary Atherectomy. , This ...
(Date:5/5/2016)... ... May 05, 2016 , ... While the practice and ... to the impact our aging population has on communities and resources. Aging Life Care ... for and face age-related challenges. , Aging Life Care is a holistic, client-centered ...
(Date:5/5/2016)... Chicago, Illinois (PRWEB) , ... May 05, 2016 ... ... published its “deeming regulations” for electronic cigarettes, requiring e-cigarette manufacturers to submit ... as a “tobacco product,” apply to all vaping products that entered the market ...
(Date:5/5/2016)... ... ... from Friday, May 6 - Sunday, May 8, fifteen elite athletes from Team Semper ... Mountain Bike Camp, hosted in conjunction with WTB and Cannondale in ... who’ll share pro tips with the injured veterans as they rip down some of the ...
(Date:5/5/2016)... , ... May 05, 2016 , ... LELO ... self-love. Every day, LELO fans reach out via email, social media and on the ... upcoming up: “Is the way I masturbate ‘normal’ or ‘correct’?” , While some methods ...
Breaking Medicine News(10 mins):